Bg pattern

DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: Information for the patient

DulcoLax Picosulfate 7.5 mg/ml oral drops

Sodium picosulfate

Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if your symptoms worsen, if there is no bowel movement after 12 hours after taking the maximum daily dose, or if there is no improvement after 6 days of treatment.

Contents of the leaflet

  1. What DulcoLax Picosulfate is and what it is used for
  2. What you need to know before taking DulcoLax Picosulfate
  3. How to take DulcoLax Picosulfate
  4. Possible side effects
  5. Storage of DulcoLax Picosulfate
  6. Package contents and additional information

1. What DulcoLax Picosulfate is and what it is used for

The active ingredient of this medication, sodium picosulfate, belongs to a group of medications called stimulant laxatives.

It is used for the symptomatic relief of occasional constipation in adults and children over 6 years of age.

If your symptoms worsen, if there is no bowel movement after 12 hours after taking the maximum daily dose, or if your symptoms persist after 6 days of treatment, you should consult your doctor.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking DulcoLax Picosulfate

It is recommended to drink 6 to 8 glasses of liquid daily when using any type of laxative to help soften the stools.

Do not takeDulcoLax Picosulfate

  • If you are allergic to sodium picosulfate or any of the other components of this medication (listed in section 6).
  • If you have symptoms such as nausea, vomiting, severe abdominal pain, and/or fever, which may indicate the presence of appendicitis or other abdominal problems.
  • If you suffer from any acute inflammatory intestinal disease, intestinal obstruction (ileus), gastrointestinal perforation, severe abdominal pain, or if you notice blood in your stools.
  • If you notice sudden changes in bowel habits (frequency and consistency of stools) that persist for more than 2 weeks.

Warnings and precautions

Consult your doctor or pharmacist before starting to take DulcoLax Picosulfate.

  • Like all laxatives, DulcoLax Picosulfate should not be taken continuously on a daily basis or for prolonged periods without investigating the cause of constipation. Prolonged excessive use can cause water and electrolyte loss (diarrhea).
  • Do not use this medication to try to lose weight. This product does not reduce caloric absorption in the intestine and can cause serious side effects. This product, like other stimulant laxatives, does not help with weight loss.
  • When administered to elderly people for prolonged periods, it can worsen states of fatigue and/or weakness or cause a decrease in blood pressure and lack of coordination.
  • There have been reports of dizziness and/or fainting in patients who have used sodium picosulfate. Based on available information, these may be due to a vasovagal response (e.g., to abdominal spasms or defecation) and not necessarily to the use of sodium picosulfate.

Children

In children under 6 years of age, administer only under medical supervision.

Other medications and DulcoLax Picosulfate

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

The simultaneous use of diuretics (medications used to increase urine elimination) or adrenocorticosteroids may increase the risk of electrolyte imbalance if excessive doses of DulcoLax Picosulfate are taken. An electrolyte imbalance can lead to increased sensitivity to cardiac glycosides (medications used for the heart).

The simultaneous administration of antibiotics may reduce the laxative effect of DulcoLax Picosulfate.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

No studies have been conducted on the effect on fertility in humans.

Driving and using machines

There are no specific studies on the ability to drive vehicles and use machines.

During treatment with this medication, dizziness and/or fainting can occur due to a vasovagal response (e.g., to abdominal spasms). If you experience abdominal spasms, you should avoid potentially hazardous tasks such as driving or operating machines.

DulcoLax Picosulfate contains sorbitol (E-420), sodium benzoate (E-211), and sodium

This medication contains 450 mg of sorbitol per ml.

Sorbitol is a source of fructose. If your doctor has told you (or your child) that you have an intolerance to certain sugars, or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medication.

Sorbitol can cause gastrointestinal discomfort and a mild laxative effect.

This medication contains 2 mg of sodium benzoate per ml. Sodium benzoate can cause jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).

This medication contains less than 1 mmol of sodium (23 mg) per ml; that is, it is essentially "sodium-free".

3. How to take DulcoLax Picosulfate

Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly. If in doubt, ask your doctor or pharmacist.

The recommended dose is:

Adults and adolescents over 12 years:

8 to 12 drops per day (4 to 6 mg of sodium picosulfate), in a single dose.

This means a maximum daily dose of 12 drops (6 mg of sodium picosulfate).

Use in children and adolescents

Children and adolescents from 6 to 12 years:

2 to 8 drops per day (1 to 4 mg of sodium picosulfate), in a single dose.

This means a maximum daily dose of 8 drops (4 mg of sodium picosulfate).

It is recommended to start with the lowest dose. The dose can be adjusted up to the maximum recommended dose capable of producing regular bowel movements.

Do not exceed the maximum recommended daily dose.

Method of administration

It should be administered orally.

The drops can be taken alone or dissolved in any type of drink (water, milk, fruit juice, etc.) or food (purées, mush, etc.).

DulcoLax Picosulfate should be administered at night, to produce evacuation the next morning. It should be administered in a single dose per day.

If your symptoms worsen, if there is no bowel movement after 12 hours after taking the maximum daily dose, you should consult your doctor.

It should not be used for more than 6 consecutive days without consulting a doctor.

If you think the effect of DulcoLax picosulfate is too strong or too weak, inform your doctor or pharmacist.

If you take more DulcoLax Picosulfate than you should

Gastrointestinal spasms, mucous and diarrheal stools, fluid loss, potassium, and other electrolytes may occur.

At much higher doses than recommended, cases of ischemia (decreased blood flow) in the colon mucosa have been reported.

Like all laxatives, continuous use of high doses of laxatives can cause chronic diarrhea, abdominal pain, decreased potassium in the blood, secondary hyperaldosteronism, and kidney stones. Renal tubular lesions, metabolic alkalosis (increased bicarbonate in the blood), and muscle weakness due to decreased potassium levels in the blood have also been reported.

If you have taken more DulcoLax picosulfate than you should, go to a medical center or call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take DulcoLax Picosulfate

Do not take a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, DulcoLax Picosulfate can cause side effects, although not everyone will experience them.

Very common side effects (may affect at least 1 in 10 patients):

  • diarrhea

Common side effects (may affect more than 1 in 10 people)

  • colic
  • abdominal pain
  • abdominal discomfort

Uncommon side effects (may affect up to 1 in 100 people)

  • vomiting
  • nausea
  • dizziness

Side effects of unknown frequency (cannot be estimated from available data)

  • hypersensitivity (allergic reactions)
  • angioedema (inflammation under the skin surface)
  • skin reactions
  • fainting
  • skin rash
  • swelling of the skin or mucous membranes (exanthema)
  • itching

The dizziness and fainting that occur after administration of DulcoLax Picosulfate seem to be consistent with a vasovagal response (e.g., to abdominal spasms or defecation).

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of DulcoLax Picosulfate

Keep this medication out of sight and reach of children.

Do not store above 30°C.

Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Do not use after 6 months of opening the packaging for the first time.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of DulcoLax Picosulfate

  • The active ingredient is sodium picosulfate. Each ml (15 drops) contains 7.5 mg of sodium picosulfate.
  • The other components (excipients) are: sodium benzoate (E-211), sorbitol liquid (E-420), sodium citrate dihydrate, citric acid monohydrate, and water.

Appearance of the product and package contents

DulcoLax Picosulfate is presented as oral drops in a slightly viscous, clear, colorless or slightly yellowish or light brownish solution.

It is presented in a 30 ml transparent plastic bottle with a dropper and screw cap.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Opella Healthcare Spain, S.L.

C/ Rosselló i Porcel, 21

08016 - Barcelona

Spain

Sanofi Group

Manufacturer:

Istituto De Angeli, S.r.l.

Localita i Prulli- 50066 Reggello (Florence)

Italy

Date of the last revision of this leaflet: October 2024

You can access detailed and updated information about this medication by scanning the QR code included in the leaflet with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/49903/P_49903.html

Square QR code with black and white modules arranged in a complex pattern

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS

Discuss questions about DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS?
DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS?
The active ingredient in DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS is sodium picosulfate. This information helps identify medicines with the same composition but different brand names.
Who manufactures DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS?
DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS is manufactured by Opella Healthcare Spain S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DULCOLAX PICOSULFATE 7.5 mg/ml ORAL DROPS?
Other medicines with the same active substance (sodium picosulfate) include EVACUOL 7.5 mg/ml Oral Drops in Solution, LUBRILAX 7.5 mg/ml ORAL DROPS IN SOLUTION, CASTOR OIL REIG JOFRE 1g/ml ORAL LIQUID. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media